Search PubMed⌕ Search

Biomedical subjects

J E Wheaton

Publications and source records attributed to J E Wheaton.

At least 37 records · Page 2Linked to original sources
PubMed1992

Influence of glucose infusions on luteinizing hormone secretion in the energy-restricted, primiparous, lactating sow.

The objective of this experiment was to evaluate the influence of glucose infusion during lactation on LH secretion in the energy-restricted sow. Ten primiparous Landrace x Yorkshire sows (152 kg postfarrowing) were fed a low-energy (6.5 Mcal of ME/d), high-lysine (45 g/d), corn-soybean meal diet throughout lactation. On d 18 of lactation, sows received a continuous infusion (1 L/12 h) of glucose (50% dextrose solution) or .9% saline from 1200 to 2400. Blood samples were drawn every 15 min for an 18-h period on d 18 to evaluate concentrations of plasma glucose, serum insulin, and serum LH before (600 to 1200) and during (1215 to 2400) the infusions. The glucose infusion immediately increased (P less than .001) plasma glucose and serum insulin relative to preinfusion levels. Glucose and insulin concentrations in sows receiving the glucose infusion were higher (P less than .001) throughout the infusion period relative to concentrations in sows receiving a saline infusion. Glucose infusions had no influence on LH pulsatility during the 12-h infusion period. In contrast to the response observed in the nutrient-restricted gilt, these results indicate that glucose infusions do not result in an immediate increase in pulsatile LH secretion in the energy-restricted, lactating sow.

Animals↗
PubMed1992

Accelerated lambing using exogenous progesterone and the ram effect.

An experiment was conducted to determine whether controlled internal drug release devices-type G (CIDR-G) could be used in conjunction with the ram effect to advance the breeding season and lambing and thereafter could be reapplied to stimulate breeding of ewes to produce a second lambing in late summer. Finn crossbred and Columbia ewes were treated with CIDR-G from July 6 to 18. Rams, which had been isolated from ewes, were joined with the flock upon CIDR-G removal. All 59 CIDR-G-treated ewes exhibited estrus, and 55 lambed from breeding within a 30-d period after CIDR-G withdrawal. Eighteen of 19 contemporary control ewes (no CIDR-G) were bred, and 16 lambed. Ewes that had lambed from the CIDR-G and control groups were retreated as before, with CIDR_G inserted March 1 and withdrawn March 13, concomitant with sudden exposure to rams. Of 55 CIDR-G-treated sheep, 53 were bred and 45 lambed. All 16 control ewes were bred and lambed. A second experiment was conducted to determine whether treatment with CIDR-G and the ram effect was effective in mid-spring. The CIDR-G were applied for 12 d and removed on May 1 or 6 from Finn crossbred, Columbia, and Polypay ewes. Rams were introduced upon CIDR-G withdrawal. Of 59 CIDR-G-treated ewes, 58 exhibited estrus and 45 lambed. Twenty-three of 30 contemporary control ewes were bred, and 20 lambed.(ABSTRACT TRUNCATED AT 250 WORDS)

Administration, Intravaginal↗
PubMed1992

Plasma concentrations of luteinizing hormone and adrenocorticotropic hormone in blood collected during the luteal and follicular phases of the estrous cycle in cows.

Luteinizing hormone (LH) and ACTH concentrations were measured in plasma from 7 cows to determine whether ACTH secretion changes with the phase of the estrous cycle, and to determine whether any ACTH peaks are associated with LH peaks. Blood was collected every 5 minutes for 190 minutes during the luteal and follicular phases of the estrous cycle. Radioimmunoassays were used to measure ACTH and LH in plasma. Mean concentration of ACTH in all cows did not differ significantly between luteal (35.1 +/- 8.0 pg/ml) and follicular (37.5 +/- 9.4 pg/ml) phases of the estrous cycle. Mean concentration of luteal-phase LH of all cows (2.0 +/- 1.1 ng/ml) was significantly (P less than 0.01) lower than mean concentration of follicular-phase LH (5.4 +/- 1.6 ng/ml). Frequency of peaks in ACTH concentration was low during the sampling period. Mean number of luteal-phase ACTH peaks (0.29 +/- 0.49) was not significantly different from that of follicular-phase samples (0.43 +/- 0.530). Unlike ACTH, mean frequency of LH peaks was significantly (P less than 0.05) higher in plasma from cows in the follicular phase of the estrous cycle (2.9 +/- 0.7), compared with that from cows in the luteal phase (0.29 +/- 0.49).

Adrenocorticotropic Hormone↗
PubMed1991

Antiserum to an inhibin alpha-chain peptide neutralizes inhibin bioactivity and increases ovulation rate in sheep.

A synthetic fragment representing the N-terminal 25 amino acid residues of the alpha-subunit of ovine inhibin (alpha-IF) was coupled to human alpha-globulin (h alpha-G) and used as an antigen. In Exp. 1, ovine antiserum generated against alpha-IF-h alpha-G was shown in vitro to neutralize inhibin bioactivity contained in ovine follicular fluid. In Exp. 2, 18 lambs were immunized with .3, .6 and 1.2 mg alpha-IF-h alpha-G or equivalent doses of h alpha-G. Antibody titer to alpha-IF was detected only in serum from lambs immunized against alpha-IF-h alpha-G and was first detected 27 +/- 2 d after primary immunization. Thereafter, antibody titers increased steadily. The degree of antibody responses was unrelated to antigen dose and differed among lambs. Plasma FSH concentrations were unchanged, whereas LH concentrations were lower (P less than .001) in sheep immunized against alpha-IF-h alpha-G. Ovulation rate was increased (3.5 +/- .5 vs 1.5 +/- .1; P less than .01) in lambs immunized against alpha-IF-h alpha-G. Ovulation rate was similar among animals receiving different antigen doses and increased with time after primary immunization (P less than .01). At estrous periods occurring approximately 34, 50, 74 and 107 d after primary immunization, respective ovulation rates were 157, 169, 207 and 450% of control values. Ovulation rate and antibody titer were correlated positively (pooled r = .95; P less than .01) within lambs. In Exp. 3, three lambs were immunized with .25 mg unconjugated alpha-IF; this was nonantigenic. In conclusion, the use of a synthetic fragment of the alpha-subunit of ovine inhibin as a hapten elicits an antibody capable of neutralizing inhibin bioactivity in vitro and increasing ovulation rate in vivo.

Alpha-Globulins↗
PubMed1990

Growth performance and carcass composition of lambs infused for 28 days with a growth hormone-releasing factor analogue.

A human growth hormone-releasing factor analogue, [DesNH2Tyr1,D-Ala2,Ala15]hGRF(1-29)NH2 (GRF-A), was infused s.c. into lambs for 28 d to determine its effects on growth performance and carcass composition. Twenty crossbred wethers weighing 47.0 +/- .5 kg were implanted with 7-d osmotic minipumps at weekly intervals. Minipumps contained either vehicle (dimethyl sulfoxide:H2O, 1:1) or GRF-A, released at a rate of 208 pmol (or .7 micrograms).h-1.kg-1. During the infusion period, plasma GH levels were increased (P less than .01) in GRF-A-treated wethers compared with control wethers (15.0 vs 9.3 ng/ml) and were higher on days that closely followed minipump implantation. Plasma IGF-I and hepatic IGF-I RNA concentrations were similar in lambs of both groups. Analogue treatment improved feed conversion (4.9 vs 5.8 kg dry matter/kg gain, P less than .05), increased average daily gain (.35 vs .30 kg, P = .05) and had no effect on feed intake, wool growth and body, carcass, selected organ and pituitary weights. Carcasses from GRF-A-infused lambs had less adjusted fat depth, a lower percentage of fat and a higher percentage of protein (P less than .05) than carcasses from control lambs. Magnitude of most effects of GRF-A on carcass measurements were correlated with the mean GH level that a lamb had during the infusion period. In conclusion, s.c. infusion of GRF-A improved feed utilization and altered carcass composition of feeder lambs in a relatively short period of time (28 d).

Animals↗
PubMed1990

Effects of melatonin and progesterone administered to ewes in spring and summer.

Melatonin (MEL) was evaluated for effects on LH, prolactin (PRL) and fertility in spring (Exp. 1, 2) and summer (Exp. 3 to 5). In Exp. 1, 17 ovariectomized ewes bearing estradiol implants were fed 3 mg MEL or vehicle for 44 d beginning May 1. Melatonin decreased (P less than .001) PRL levels but had no effect on LH secretion and response to GnRH. In Exp. 2, 12 ewes each received a 40-d MEL ear implant or a sham implant on March 31. Progesterone-releasing pessaries (CIDR) were applied for 12 d and were withdrawn concomitant with ram joining on May 7. Neither treatment stimulated follicular development or induced estrus or ovulation. Exp. 3 and 4 were contemporary 2 x 2 factorial trials with 24 ewes at each of two locations. Melatonin implants were administered on June 29 and CIDR on July 22. The CIDR were removed and rams (Exp. 3, vasectomized; Exp. 4, fertile) were joined on August 3. Days from introduction of rams to estrus were reduced (P less than .05) by CIDR but not by MEL. All ewes lambed in Exp. 4, and days to estrus and conception were reduced (P less than .001) by CIDR but not by MEL. Exp. 5 was designed like Exp. 4 except that MEL implants were inserted June 20 and rams were joined August 8. Intervals from introduction of rams to estrus were reduced (P less than .01) by both MEL and CIDR treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Anestrus↗
PubMed1990

Somatotropin treatment for a second consecutive lactation.

Twenty-five Holstein cows were used to examine effects of recombinant bST administration for a second successive lactation on milk yield and composition, BW change, body condition, and health. Treatments were 0 (physiological saline), 10.3, 20.6, and 33 mg bST/d (8, 8, 7, and 3 cows per treatment, respectively). Saline and bST were given daily as subcutaneous injections beginning 4 to 5 wk postpartum and continuing for 38 wk. Somatotropin increased 3.5% FCM yield linearly from 8 to 36% over controls (control FCM was 30.1 kg/d). Milk composition was not affected by bST except that milk from cows given the 10.3-mg dosage had slightly higher Ca and P contents than did milk from cows receiving 0 or 20.6 mg. Cows receiving bST were 9 to 30% more efficient than controls in converting feed to milk. Body weight gain was unaffected by treatment. Average condition score was unchanged for control cows during the first 84 d following initiation of treatment, but declined in cows given bST. Thereafter, condition score increased in a similar manner for all groups. No treatment-related patterns were found in incidence of mastitis, feet and leg problems, ketosis, or milk fever. Blood hormone, chemistry, and hematology revealed no effects of bST treatment other than to raise plasma bST concentrations. Under conditions of this experiment, use of bST during a second consecutive lactation did not change the normal physiology or productive capacity of lactating cows.

Animal Feed↗
PubMed1989

Cloning of ovine insulin-like growth factor-I cDNAs: heterogeneity in the mRNA population.

We have isolated and characterized lamb liver cDNAs encoding ovine insulin-like growth factor-I (oIGF-I) precursor polypeptide to study IGF-I gene expression in ruminants. Four cDNA clones were sequenced revealing two different exon 1 sequences (designated 1A and 1B) and four different putative poly(A) adenylation sites. cDNAs containing exon 1A or exon 1B encode precursor polypeptides of 138 or 154 amino acids, respectively. A 130-amino-acid peptide is encoded by all cDNAs examined. These precursors include a hydrophobic leader peptide of varying lengths, the 70-amino-acid oIGF-I, and a 35-amino-acid carboxyl terminal extension peptide. The predicted amino acid sequence of the oIGF-I peptide differs from the human, bovine, and porcine IGF-Is at a single amino acid (at position 66, alanine is substituted for proline) and differs from rat and mouse IGF-Is at 4 and 5 positions, respectively. Both the amino- and carboxy-terminal extension peptides showed regions of extensive sequence homology. Ovine IGF-I amino-terminal peptides are 1 amino acid longer than other mammalian IGFs due to the presence of an extra amino acid (glutamine) present at the proposed boundary of exon 1 and exon 2. Northern blot analysis revealed multiple oIGF-I transcripts in a broad band at 800-1,100 nucleotides and other transcripts of higher molecular weight in liver. There was no detectable expression in either spleen or brain.

Amino Acid Sequence↗
PubMed1988

Plasma gonadotropin and progesterone concentrations during the estrous cycle of Finn, Suffolk and Targhee ewes.

Hormonal profiles during the estrous cycle of Finn, Suffolk and Targhee ewes were compared in six ewes of each breed. Blood samples were drawn by venipuncture at 8-h intervals from onset to onset of consecutive estrous periods. Number of corpora lutea (CL) and ovarian follicles >/=3 mm in diameter on Day 10 (estrus = Day 0) were observed using endoscopy. Estrous cycle length was 14.9, 15.6 and 16.4 d (P<0.01) in Finn, Suffolk and Targhee ewes, respectively. Finns had more (P<0.001) CL (3.5) than Suffolks (2.0) and Targhees (1.8), but luteal phase progesterone concentrations were similar among breeds in peak level and area under the curve. In Finn ewes, the amplitude of the preovulatory LH surge was lower (P<0.01) and tended to occur later in estrus; otherwise LH levels and patterns were similar among breeds. A coincident follicle stimulating hormone (FSH) preovulatory surge occurred in most ewes, the amplitude of which was related to that of luteinizing hormone (LH); r = 0.67, P<0.01. Plasma FSH levels and patterns were similar in Finn, Suffolk and Targhee ewes and most ewes had three to four secretory episodes. Follicles >/=3 mm averaged 1.8, 1.0 and 1.2 (P>0.1) in Finn, Suffolk and Targhee ewes, respectively. Results indicate that the higher ovulation rate of the Finn ewe is not elicited by increased FSH levels at any stage of the estrous cycle.

Journal Article↗
PubMed1988

Neonatal hemiorchidectomy of bulls alters plasma growth hormone levels and advances onset of pubertal testosterone secretion.

Bovine GH and testosterone profiles were determined in plasma collected at 20 min intervals during 3 hr bleeding periods on day 25 of life and every 15 days thereafter in six intact (I) Holstein bull calves and in six others which had been hemiorchidectomized (HO) at 10 days of age. In I bulls average plasma GH concentrations varied between 7.9 and 14.5 ng/ml (P greater than 0.05) until 130 days of age, after which the GH level gradually rose (P = 0.007) to a maximum of 19.4 ng/ml on day 205 of life. Episodic release of GH was apparent in 55 day-old and older I bulls and in HO bulls of all ages. Plasma GH concentrations in HO bulls were higher than in I bulls 15 and 30 days after surgery (P = 0.07), at which times the levels in HO bulls averaged 19.6 and 22.5 ng/ml and in I bulls 10.3 and 10.2 ng/ml, respectively. Plasma GH in HO bulls again exceeded that of I bulls at ages of 130-190 days (P = 0.04). Plasma testosterone was virtually nondetectable before 130 days of age in I bulls but thereafter exhibited the typical episodic pattern. In HO bulls, plasma testosterone concentrations began to rise 15 to 30 days before those in I bulls, resulting in an age X treatment interaction (P less than 0.0001). Furthermore, average testosterone levels were higher (P = 0.07) in HO than I bulls at 235 and 250 days of age.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1988

Use of osmotic pumps for subcutaneous infusion of growth hormone-releasing factors in steers and wethers.

Osmotic pumps were evaluated for 7-d delivery of growth hormone-releasing factor (GRF). In Exp. 1, 12 steers weighing 253 kg received hGRF(1-29)NH2 in H2O at rates of 0, 3, 30 and 300 pmol.h-1.kg-1. Pumps were implanted s.c. on d 0 and removed at 1200 on d 7. Blood samples were drawn at 20-min intervals from 0800 to 1200 on d -1, 1, 3, 5, 7 and 9. Growth hormone levels were not altered by GRF treatment (P greater than .05). Solubility and volume limitations render hGRF(1-29)NH2 delivery via osmotic pumps problematical. Flow rate and duration of release of dimethyl sulfoxide (DMSO):H2) (1:1) from osmotic pumps incubated in vivo and in vitro were found to be consistent with manufacturer's specifications. Two hGRF(1-29) analogues, Ro23-7863 and 4SG-29, were dissolved in DMSO:H2O. In Exp. 2, six 222-kg steers had pumps implanted and blood samples were taken as in Exp. 1. Three steers received each analogue at a rate of 300 pmol.h-1.kg-1. Analogues had similar GH-releasing ability and GH levels differed (P less than 0.001) among days, being approximately fourfold higher on d 3, 5 and 7 than on d -1, 1 and 9. Residual analogue solutions retained full bioactivity after 7-d implantation, and in vitro biopotencies of Ro23-7863 and 4SG-29 were similar (Exp. 3). In Exp. 4, 15 wethers (means = 31.3 kg) received osmotic pumps delivering 0, 3, 15, 75 and 300 pmol.h-1.kg-1 Ro23-7863 in DMSO:H2O for 7 d. Lambs were bled at 0800 and 1400 from d -1 to 8. The latter two doses increased (P less than .01) mean GH levels 2.7- and 4.3-fold over those in control animals during the treatment period. Results demonstrate that increased GH secretion can be elicited in steers and wethers for 1 wk by continuous s.c. infusion of GRF analogues utilizing osmotic pumps.

Animals↗
PubMed1988

Effects of recombinant bovine somatotropin on milk production, body composition, and physiological parameters.

Twenty-eight multiparous Holstein cows were utilized to determine effects of long-term administration of recombinant bovine somatotropin on lactational performance, body condition, body composition, hormones, blood constituents, and physiological parameters. Treatments were 0 (control), 10.3, 20.6, and 41.2 mg recombinant bovine somatotropin administered daily as subcutaneous injections beginning 4 to 5 wk postpartum and continuing for 38 wk. A total mixed diet of 28% corn silage, 22% alfalfa hay cubes, and 50% corn-soybean meal-based grain mixture was fed. Fat-corrected milk yields were increased 12 to 25% for cows treated with somatotropin as compared with controls (29.9 kg/d). Milk composition was similar among treatments. Cows receiving somatotropin consumed 4 to 10% more feed and were 11 to 17% more efficient than controls for conversion of feed to milk. Body weight changes were not significantly different among treatments, but cows receiving somatotropin gained 4 to 10% less weight than controls. Body fat (kg) of cows receiving 20.6 and 41.2 mg/d was less than that of cows receiving 10.3 mg/d or no somatotropin. Estimated weights of body protein and mineral, most blood constituents, respiratory rates, and body temperature were not affected by somatotropin administration. Plasma fatty acids were elevated and hematocrit values were reduced. Plasma insulin, serum somatotropin, and heart rate increased concurrently with somatotropin administration.

Animals↗
PubMed1987

Endocrine responses in relation to compensatory testicular growth after neonatal hemicastration in boars.

Mass (TM) and relative mass (organ mass/body mass; RTM) of the right testis and epididymis (EM and REM, respectively) were determined every 14 days from 10 to 122 days of age for intact boars (I) and boars hemicastrated on Day 10 (HC) in two crossbred herds (Trial 1 and Trial 2). Plasma follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, growth hormone (GH), and testosterone were determined in four blood samples from each pig, three collected 24 h prior to castration and one immediately prior to castration. Values for TM and RTM of HC boars were approximately double (p less than 0.0001) those of I boars by 38 days of age, and these differences were maintained through Day 122. Both EM and REM were greater (p less than 0.05) in HC than in I boars from Day 52 to Day 122. The TM, RTM, EM and REM were greater (p less than 0.05) in Trial 1 than in Trial 2 for both I and HC boars from Day 80 to Day 122, indicating an earlier onset of pubertal testicular growth in the Trial-1 boars. Plasma GH concentration was greater (p less than 0.05) in HC than in I boars from Day 16 to Day 38. A transient increase in plasma FSH (p less than 0.05) was observed from Day 24 to Day 38. After Day 38, there was no difference (p greater than 0.05) in FSH or GH between HC and I boars, or between trials. Plasma LH, prolactin, and testosterone concentrations were also similar in HC and I boars.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1986

Twenty-four-hour growth hormone profiles in Angus steers.

A study was conducted in February 1984 to characterize plasma growth hormone (GH) patterns in steers. Eight Angus steers averaging 285 d of age and 276 kg were housed in a sheltered pen and group-fed once daily. Animals gained at a mean rate of .78 kg/d, with individuals ranging from .34 to 1.02 kg/d. A jugular vein cannula was inserted the day before blood sampling, which commenced at 0600 h and continued at 15-min intervals for 24 h. Growth hormone patterns consisted of frequent GH surges of varying amplitude. Growth hormone surges occurred at an average frequency of .7/h. This rate did not differ markedly among steers nor hour of day. The magnitude of GH secretory surges varied significantly among steers and during the 24-h period. Growth hormone peaks averaged 47.0 and 27.2 ng/ml in steers having the highest and lowest GH surges, respectively. During the 24-h period there were two to four 2- to 3-h periods in which GH surges were reduced in amplitude. These trough periods occurred at approximately 6-h intervals in two steers, imparting rhythmicity to GH profiles of these animals. Periods of reduced surge amplitudes and intervening secretory episodes were less periodic in the other steers. Steers were fed at 1400 h and in all steers GH levels fell from 1400 to 1600 h, and then rebounded with two to four high amplitude surges. Peak and mean GH levels were associated positively (r = .93, P less than .01) and both were associated negatively with rates of gain (r = -.82 and -.74, respectively; P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1985

Growth hormone response to growth hormone-releasing factor in selected and control Holstein heifer calves.

Holstein heifer calves from selected and control lines were treated with growth hormone-releasing factor to determine whether the magnitude of the pituitary growth hormone response is associated with genetic potential for milk yield. Cows in the selected line were bred to highest Predicted Difference milk sires available each year, while control line cows were bred to bulls that were average for 1964 milk production. Eight calves from each line of similar age (206 to 210 days) and weight (205 kg average) were injected intravenously with .1 microgram/kg growth hormone-releasing factor. Dams' first lactation 305-day mature equivalent records were 10,192 +/- 495 kg for selected calves and 6,908 +/- 376 kg for control calves. Before treatment, GH tended to be higher in selected than control calves (mean +/- SE: selected = 7.5 +/- 1.8, control = 4.6 +/- .4 ng/ml). After injection, peak GH were reached within 20 min and were similar in selected and control calves, averaging 66 +/- 16 and 73 +/- 13 ng/ml, respectively. Results indicate that the magnitude of the growth hormone response to growth hormone-releasing factor is not related to future performance of dairy calves.

Animals↗
PubMed1982

Peripheral plasma levels of luteinizing hormone-releasing hormone-like immunoreactivity and luteinizing hormone in anestrous and ovariectomized sheep.

Low levels of endogenous LHRH-like immunoreactivity (IR) were consistently detected in methanolic extracts of plasma samples from anestrous and ovariectomized sheep. Mean concentrations were similar in magnitude in the intact and castrate ewes (7.7 +/- 7.0 and 6.1 +/- 0.8 pg/ml, respectively) but revealed greater within animal fluctuations in the ovariectomized sheep (CVs: anestrous ewes = 20 +/- 3%; ovariectomized ewes = 45 +/- 10%). Patterns of plasma LHRH-like IR and LH levels were not obviously related. Differences in levels of LHRH-like IR did exist between ewes and in the ovariectomized sheep the levels were positively correlated (r = .83, P less than ,05) with the pituitary LH response to synthetic LHRH injection (0.25 micrograms). Large plasma volumes (250 ml) were extracted using chloroform, methanol and acetic acid and then chromatographed using Sephadex LH-20. Plasma LHRH-like IR could be concentrated and was found to have a column elution volume coincidence with that of synthetic LHRH. These data indicate that there is a substance in ovine plasma which is close in size, solubility and IR to sLHRH. It does not reflect LH levels in either magnitude or pattern but does exhibit a coincident increase in variation with plasma LH levels following ovariectomy and appears to be associated with the pituitary responsiveness.

Animals↗
PubMed1982

Effects of progesterone treatment on basal and LH-RH-induced plasma LH concentrations in anoestrous and ovariectomized sheep.

Anoestrous and ovariectomized sheep were treated with progesterone-containing implants or left as controls. Plasma LH concentrations were decreased by progesterone treatment (P less than 0.025) and increased by ovariectomy (P less than 0.001). When the ewes were treated with 0.25 micrograms LH-RH, the LH response was reduced (P less than 0.025) in the progesterone-treated anoestrous ewes but not in the progesterone-treated ovariectomized sheep. These data demonstrate that low concentrations of progesterone, acting together with another ovarian hormone, can markedly reduce the pituitary response to a small dose of LH-RH.

Anestrus↗